4'-(2-Butyl-4-oxo-4,5-dihydro-imidazo[4,5-c]pyridin-3-ylmethyl)-biphenyl-2-carboxylic acid

ID: ALA288705

PubChem CID: 10092454

Max Phase: Preclinical

Molecular Formula: C24H23N3O3

Molecular Weight: 401.47

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCc1nc2ccnc(O)c2n1Cc1ccc(-c2ccccc2C(=O)O)cc1

Standard InChI:  InChI=1S/C24H23N3O3/c1-2-3-8-21-26-20-13-14-25-23(28)22(20)27(21)15-16-9-11-17(12-10-16)18-6-4-5-7-19(18)24(29)30/h4-7,9-14H,2-3,8,15H2,1H3,(H,25,28)(H,29,30)

Standard InChI Key:  RZINJLAVRWFBLD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.1417   -1.2042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7167   -1.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7167   -0.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1417   -0.2292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2125   -0.7167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2292   -1.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2333   -4.0875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6708   -3.8750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6958   -3.7042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2292   -0.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7500   -1.0167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3833   -1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7500   -0.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5750   -3.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2292   -1.9167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6000   -3.1167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0125   -3.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0458   -2.9000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3833   -2.1000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2583   -3.9167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8125   -0.7167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0792   -2.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9458   -2.3042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3250   -4.6792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2083   -4.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1125   -0.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7125   -0.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8583   -5.0542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2958   -4.8417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0125    0.3208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  2  0
  4  5  2  0
  5  1  1  0
  6  2  1  0
  7  8  2  0
  8 14  1  0
  9  7  1  0
 10  3  1  0
 11  6  2  0
 12  1  1  0
 13 11  1  0
 14 18  2  0
 15  6  1  0
 16  9  2  0
 17 22  2  0
 18 23  1  0
 19 12  1  0
 20  9  1  0
 21  5  1  0
 22 19  1  0
 23 19  2  0
 24  7  1  0
 25  8  1  0
 26 21  1  0
 27 26  1  0
 28 29  1  0
 29 25  2  0
 30 27  1  0
  3  4  1  0
 14 17  1  0
 10 13  2  0
 24 28  2  0
M  END

Associated Targets(Human)

AGTR2 Tchem Angiotensin II type 2 (AT-2) receptor (2549 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Agtr1b Angiotensin II receptor (AT-1) type-1 (1480 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 401.47Molecular Weight (Monoisotopic): 401.1739AlogP: 4.89#Rotatable Bonds: 7
Polar Surface Area: 88.24Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.57CX Basic pKa: 4.30CX LogP: 4.46CX LogD: 2.00
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.46Np Likeness Score: -0.85

References

1. Mederski WW, Dorsch D, Bokel HH, Beier N, Lues I, Schelling P..  (1994)  Non-peptide angiotensin II receptor antagonists: synthesis and biological activity of a series of novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridine derivatives.,  37  (11): [PMID:8201597] [10.1021/jm00037a014]
2. Sharma MC, Kohli DV.  (2013)  A comprehensive structureactivity analysis 2,3,5-trisubstituted 4,5-dihydro-4-oxo-3H-imidazo [4,5-c] pyridine derivatives as angiotensin II receptor antagonists: using 2D- and 3D-QSAR approach,  22  (2): [10.1007/s00044-012-0040-z]

Source